Lotte Chemical Corporation (011170) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
23 Sep, 2026Executive summary
Q2 2024 sales reached KRW 5.25 trillion, up 3.2% QoQ and 3.4% YoY, with operating loss narrowing to KRW 111.2 billion, driven by improved downstream demand, higher sales in advanced materials, and positive FX effects.
EBITDA was KRW 208 billion, up KRW 36.4 billion QoQ, with net income at KRW 107 billion (2.0% margin), both improving YoY.
Consolidated H1 2024 sales were KRW 10.33 trillion, with basic chemicals (68%), advanced materials (26%), fine chemicals (7.9%), and battery materials (4.9%) as core segments.
Financial highlights
Assets at end-Q2 were KRW 35.71 trillion, up KRW 579.7 billion QoQ; liabilities rose to KRW 15.34 trillion, up KRW 629.3 billion QoQ; cash and equivalents decreased by KRW 186.7 billion QoQ.
Debt-to-equity ratio stood at 75.3% as of June 2024; net debt ratio at 33.8%.
Operating loss for H1 2024 was KRW 246.4 billion, compared to a loss of KRW 347.7 billion in H1 2023.
Dividend payout for FY2023 was KRW 3,500 per share (72% payout ratio), with an interim dividend of KRW 1,000 per share in July/August 2024.
Stock buybacks totaling KRW 100 billion completed to date.
Outlook and guidance
Q3 is expected to see gradual supply-demand improvement, but profitability may remain flat due to delayed demand recovery and higher freight costs.
Advanced materials anticipate stable sales but stagnant profitability due to new Chinese capacity and rising freight costs.
LOTTE Fine Chemical expects continued revenue growth in Q3, driven by higher international prices and green material sales.
LOTTE Energy Materials projects slower revenue growth in Q3 amid broad industry demand declines and policy volatility.
Ongoing investments in hydrogen, battery materials, and chemical recycling to drive future growth.
Latest events from Lotte Chemical Corporation
- Impairment losses led to deep 2024 losses, but gradual recovery and asset-light progress are expected.011170
Q4 2024 - Q3 2024 revenue was flat, losses widened, and asset sales and investments continue amid weak demand.011170
Q3 2024 - Q1 2025 losses narrowed as advanced and fine chemicals improved, but margin pressures persist.011170
Q1 2025 - Losses widened, but recovery is expected as portfolio shifts and new projects progress.011170
Q2 2025 - 2025 saw losses from weak demand and impairments, but recovery is expected through diversification.011170
Q4 2025 - Q3 2025 returned to profit, but 9M results show losses; focus shifts to battery and hydrogen.011170
Q3 2025 - Q2 2026 delivered higher profits and restructuring progress, despite ongoing market risks.011170
Q2 2026 - Q1 2026 returned to profit with KRW 4.99T revenue and KRW 49.6B net income amid ongoing risks.011170
Q1 2026